Cellular signalling · 2026
Intercellular transfer of circ_0017636 via exosomal vehicles overcomes glioblastoma chemoresistance through ARRB1-mediated signaling restoration.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Li Qiang, Xu Jianglong, Ye Bin, Jin Peikan, Bee-Lan Ong Diana, Mun Kein Seong, Geng Xiuchao, Tang Yiping, Phang Kean Chang
Аннотация
Temozolomide (TMZ) resistance represents a primary cause of treatment failure and poor outcomes in glioblastoma (GBM). Exosome-mediated intercellular communication is increasingly recognized as a pivotal mechanism driving the dissemination of chemoresistance; however, the specific contribution of exosomal circular RNA cargos to this adaptive process remains elusive. This study systematically characterized the biological function of exosomal circ_0017636 in remodeling the TMZ-resistant microenvironment. We identified that circ_0017636 was significantly downregulated in TMZ-resistant tissues and correlated with poor prognosis. Mechanistically, circ_0017636 functions as a competing endogenous RNA that physically sponges miR-665 to de-repress Arrestin Beta 1 (ARRB1). Crucially, we isolated exosomes from sensitive cells and confirmed their identity via transmission electron microscopy (TEM) and marker analysis. Utilizing CD63-GFP fluorescent tracking, we visually demonstrated the efficient internalization of these vesicles by resistant recipient cells, confirming that circ_0017636 is physically packaged into these exosomes as a transferable cargo. Upon uptake, these circ_0017636-loaded exosomes effectively propagated chemosensitivity signals, significantly reducing the expression of the proliferation marker Ki-67 and the multidrug resistance protein P-glycoprotein (P-gp), thereby suppressing malignant phenotypes. Furthermore, vivo experiments confirmed that intratumoral delivery of circ_0017636-enriched exosomes significantly retarded xenograft tumor growth and overcame TMZ resistance. Collectively, this study elucidates a novel exosome-based communication axis, wherein circ_0017636 acts as a transferable tumor suppressor. Our findings suggest that leveraging exosomes as natural vehicles to deliver circ_0017636 represents a promising therapeutic strategy, while also indicating its potential as a diagnostic biomarker.